Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis

BACKGROUND: Pulmonary fibrosis is one of the sequelae of the COVID-19, which seriously affects the quality of life of survivors. Currently, there are no optimal evidence based guidelines targeting this population. CASE PRESENTATION: We report a 66-year-old female patient without underlying comorbidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xianglin, Yang, Danhui, Kong, Xianglong, Wei, Chengli, LvQiu, Siqi, Wang, Lin, Lin, Yongkang, Yin, Zhilan, Zhou, Zhiguo, Luo, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207265/
https://www.ncbi.nlm.nih.gov/pubmed/35733875
http://dx.doi.org/10.3389/fmed.2022.925703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207265/
https://www.ncbi.nlm.nih.gov/pubmed/35733875
http://dx.doi.org/10.3389/fmed.2022.925703

Ejemplares similares